Skip to main content
Clinical Trials/TCTR20171107001
TCTR20171107001
Completed
N/A

Palliative use of nasal high-flow oxygen compared with standard therapy in do-not-intubate patients: A randomized crossover study

one0 sites38 target enrollmentNovember 7, 2017

Overview

Phase
N/A
Intervention
Not specified
Conditions
Dypsnea in do&#45
Sponsor
one
Enrollment
38
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 7, 2017
End Date
August 8, 2018
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
one

Eligibility Criteria

Inclusion Criteria

  • 1\.Age \> 18 years old
  • 2\.Do\-not\-intubate status
  • 3\.Presented with respiratory distress meeting all of the following criteria
  • a.Pulse oximetry \< 90% when breathing at room air
  • b.Dyspnea (modified Borg scale ≥ 4\)
  • c.Signs of respiratory distress e.g. accessory muscle use
  • d.Respiratory rate ≥ 30 breaths/min
  • 4\.Competent status: Kelly score \< 4

Exclusion Criteria

  • 1\.Refusal of treatment
  • 2\.Agitation or non\-cooperation
  • 3\.Adverse reactions or contraindication to opioids
  • 4\.Participants contraindicated for NHF such as excessive secretion, risk of aspiration

Outcomes

Primary Outcomes

Not specified

Similar Trials